Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to ...

Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to ...

Catalent to sell New Jersey facility Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer ...

SOMERSET, N.J. - Catalent, Inc. (NYSE ... has reached a definitive agreement to divest its Somerset, New Jersey oral solids development and small-scale manufacturing facility.

Oct 14 (Reuters) - Catalent (CTLT.N), opens new tab has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug ...

Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, ...

SOMERSET, N.J. - Catalent, Inc. (NYSE: NYSE:CTLT), a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, has reached a ...